GICS Sector : Basic Materials
Corteva, Inc.operates in the agriculture business.It operates through two segments, Seed and Crop Protection.
Corteva Agriscience reported a robust third quarter of 2025, with operating EBITDA rising 14% year-over-year to between $3.8 billion and $3.9 billion. The growth was driven by an 11% increase in organic sales, with both the Seed and Crop Protection businesses contributing to the gains. The operating EBITDA margin expanded by over 600 basis points, reflecting the company's successful cost-saving initiatives and productivity improvements. The actual EPS beat estimates, coming in at -$0.23 compared to the expected -$0.5067. Year-to-date, organic sales were up 6%, with operating EBITDA increasing 19% and margin expansion of about 320 basis points. The company has raised its full-year operating EPS guidance to $3.25 to $3.35 per share, representing a 28% increase at the midpoint.
Publication Date: Nov -06
In the Seed business, Corteva achieved $200 million in productivity and deflation benefits and $90 million in royalty improvements. The Crop Protection business delivered solid earnings and margin growth, with expected full-year EBITDA up high single digits. The company's biologicals business is growing rapidly, with sales up 7% year-to-date, driven by new products and expansion into new markets. New products such as Pyraxalt and Reklemel are seeing significant growth, up 30% year-over-year.
Corteva announced its intention to separate into two public companies, Seed and Crop Protection, to maximize long-term growth potential. The process is on schedule for a second-half 2026 separation. For 2026, the company expects low single-digit growth in the crop protection industry and mid-single-digit growth in operating EBITDA, with a range of $4.1 billion. The separation is expected to unlock value, sharpen focus, and accelerate innovation.
With a P/E Ratio of 26.92 and an EV/EBITDA of 12.19, the market has already priced in significant growth expectations. The company's ROIC of 5.7% and ROE of 6.47% indicate a decent return on capital, but there is room for improvement. Analysts estimate next year's revenue growth at 3.5%. The company's strong R&D pipeline, including its gene editing technology and hybrid wheat technology, is expected to drive future growth. The Crop Protection business has a strong portfolio, including the Spinosyn franchise, expected to reach $900 million in revenue this year.
Corteva is managing its risk well in Latin America, with minimal losses and a robust barter system reducing exposure. The company is open to M&A and partnerships to enhance its biologicals portfolio, which is growing rapidly. With a fragmented biologicals industry, the company may consider outright acquisitions, commercial collaborations, or R&D partnerships to drive growth.
Brandes Investment Partners LP Has $174.08 Million Stake in Corteva, Inc. $CTVA
Dec -02
Avantax Advisory Services Inc. Boosts Stock Position in Corteva, Inc. $CTVA
Nov -22
Bank Julius Baer & Co. Ltd Zurich Has $16.77 Million Stake in Corteva, Inc. $CTVA
Nov -21
Corteva, Inc. $CTVA Shares Acquired by Bronte Capital Management Pty Ltd.
Nov -20
17 Capital Partners LLC Has $2.44 Million Stock Holdings in Corteva, Inc. $CTVA
Nov -20
Major Indexes Gap Lower as Earnings, Jobs Data Stays in Focus
Nov -17
Allworth Financial LP Purchases 2,210 Shares of Corteva, Inc. $CTVA
Nov -14
The Smartest Dividend Stocks to Buy With $600 Right Now
Nov -13
Corteva's seed segment growth of 4.0% is driven by increased adoption of innovative and sustainable agricultural solutions, strong demand for high-yielding crop varieties, and expanding presence in emerging markets. Additionally, the company's strategic investments in digital agriculture and precision farming technologies are enhancing farmer productivity and driving growth.
Corteva, Inc.'s Crop Protection segment growth of 3.5% is driven by strong demand for sustainable agriculture solutions, increased adoption of precision farming, and a robust pipeline of innovative products, including insecticides, herbicides, and fungicides, that enhance crop yields and protect against emerging pests and diseases.
Corteva Agriscience offers a wide range of seeds for various crops, including corn, soybeans, wheat, and more. These seeds are designed to provide high yields, improved plant health, and enhanced resistance to diseases and pests.
Corteva Agriscience provides a variety of crop protection products, including insecticides, fungicides, and herbicides. These products help farmers control pests, diseases, and weeds that can damage crops and reduce yields.
Corteva Agriscience offers digital agriculture solutions, including data analytics, precision farming, and decision support tools. These solutions help farmers optimize crop yields, reduce waste, and improve resource allocation.
Corteva Agriscience has a plant breeding program that develops new crop varieties with improved traits, such as increased yields, drought tolerance, and disease resistance.
Corteva, Inc. operates in the agricultural industry, specifically in the seeds and crop protection business. While there are alternative products and solutions available, such as organic farming and biopesticides, the company has a strong portfolio of patented seeds and crop protection products, which limits the threat of substitutes.
Corteva's customers are primarily large agricultural companies and farmers. Given the company's strong brand portfolio and the critical nature of its products for agricultural productivity, customers have limited bargaining power.
Corteva has a diverse supplier base and does not rely heavily on any single supplier. The company also has significant negotiating power due to its large scale and market position.
The agricultural industry, particularly the seeds and crop protection segment, has high barriers to entry due to significant R&D investments, regulatory hurdles, and the need for a strong distribution network. This limits the threat of new entrants.
The seeds and crop protection industry is highly competitive, with major players like Monsanto (now part of Bayer), Syngenta (now part of ChemChina), and DowDuPont (Corteva's predecessor). The competition is driven by factors such as product innovation, pricing, and market share.
| Value | |
|---|---|
| Debt Weight | 10.20% |
| Debt Cost | 12.74% |
| Equity Weight | 89.80% |
| Equity Cost | 7.93% |
| WACC | 8.42% |
| Leverage | 11.36% |
Value: 6.0
Growth: 3.9
Quality: 4.7
Yield: 7.0
Momentum: 7.0
Volatility: 8.7
1-Year Total Return ->
Value: 6.7
Growth: 3.8
Quality: 4.6
Yield: 5.0
Momentum: 8.0
Volatility: 6.0
1-Year Total Return ->
Value: 1.6
Growth: 6.7
Quality: 5.7
Yield: 1.0
Momentum: 8.0
Volatility: 9.3
1-Year Total Return ->
Value: 4.2
Growth: 4.7
Quality: 6.6
Yield: 2.0
Momentum: 6.0
Volatility: 8.3
1-Year Total Return ->
Value: 1.9
Growth: 7.0
Quality: 5.8
Yield: 0.0
Momentum: 7.0
Volatility: 9.0
1-Year Total Return ->
Value: 8.2
Growth: 2.7
Quality: 1.9
Yield: 10.0
Momentum: 0.0
Volatility: 4.7
1-Year Total Return ->